Tyco Acquires Bio-Sealant Pipeline With $245 Mil. Confluent Surgical Buy
This article was originally published in The Gray Sheet
Executive Summary
Tyco Healthcare subsidiary U.S. Surgical will acquire Confluent Surgical for $245 mil. to augment its suture business with a pipeline of bioabsorbable sealants
You may also be interested in...
Covidien Surgical Device Sales Growth Of 10.5% Is Driven By Laparoscopy
Newly independent medical technology firm Covidien's surgical device sales growth of 10.5% for the quarter ended June 29 was driven by demand for autosuture laparoscopic instruments in the United States and Europe, the company reported during its fiscal third-quarter earnings call Aug. 9
Covidien Surgical Device Sales Growth Of 10.5% Is Driven By Laparoscopy
Newly independent medical technology firm Covidien's surgical device sales growth of 10.5% for the quarter ended June 29 was driven by demand for autosuture laparoscopic instruments in the United States and Europe, the company reported during its fiscal third-quarter earnings call Aug. 9
Ob/Gyn Panel Unanimously Supports Adhesion-Prevention Product Approval
Baxter's biosurgery business stands to gain from an FDA advisory panel's unanimous support for a product designed to prevent a serious side effect of certain surgical procedures. But limitations recommended for the label could curb some of the market potential if adopted by the agency in its final approval decision